Literature DB >> 25582855

Antibody-opsonized bacteria evoke an inflammatory dendritic cell phenotype and polyfunctional Th cells by cross-talk between TLRs and FcRs.

Jantine E Bakema1, Cornelis W Tuk2, Sandra J van Vliet2, Sven C Bruijns2, Joost B Vos3, Sophia Letsiou4, Christien D Dijkstra2, Yvette van Kooyk2, Arjan B Brenkman4, Marjolein van Egmond5.   

Abstract

During secondary immune responses, Ab-opsonized bacteria are efficiently taken up via FcRs by dendritic cells. We now demonstrate that this process induces cross-talk between FcRs and TLRs, which results in synergistic release of several inflammatory cytokines, as well as altered lipid metabolite profiles. This altered inflammatory profile redirects Th1 polarization toward Th17 cell responses. Interestingly, GM-CSF-producing Th cells were synergistically evoked as well, which suggests the onset of polyfunctional Th17 cells. Synergistic cytokine release was dependent on activation via MyD88 and ITAM signaling pathways through TLRs and FcRs, respectively. Cytokine regulation occurred via transcription-dependent mechanisms for TNF-α and IL-23 and posttranscriptional mechanisms for caspase-1-dependent release of IL-1β. Furthermore, cross-talk between TLRs and FcRs was not restricted to dendritic cells. In conclusion, our results support that bacteria alone initiate fundamentally different immune responses compared with Ab-opsonized bacteria through the combined action of two classes of receptors and, ultimately, may refine new therapies for inflammatory diseases.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25582855     DOI: 10.4049/jimmunol.1303126

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

2.  FcγR mediates TLR2- and Syk-dependent NLRP3 inflammasome activation by inactivated Francisella tularensis LVS immune complexes.

Authors:  Ellen B Duffy; Sivakumar Periasamy; Danielle Hunt; James R Drake; Jonathan A Harton
Journal:  J Leukoc Biol       Date:  2016-06-30       Impact factor: 4.962

3.  Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis.

Authors:  Daria A Burmistrova; Sergey V Tillib; Dmitry V Shcheblyakov; Inna V Dolzhikova; Dmitry N Shcherbinin; Olga V Zubkova; Tatiana I Ivanova; Amir I Tukhvatulin; Maxim M Shmarov; Denis Y Logunov; Boris S Naroditsky; Aleksandr L Gintsburg
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

4.  Murine macrophage TLR2-FcγR synergy via FcγR licensing of IL-6 cytokine mRNA ribosome binding and translation.

Authors:  Danielle Hunt; Lisa A Drake; James R Drake
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

Review 5.  Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins.

Authors:  Chiara Elisabeth Geyer; Lynn Mes; Melissa Newling; Jeroen den Dunnen; Willianne Hoepel
Journal:  Cells       Date:  2021-05-12       Impact factor: 6.600

6.  Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially regulates their synergistic and inhibitory receptor crosstalk.

Authors:  Wenqian Li; Miao Li; Stephen M Anthony; Yan Yu
Journal:  Sci Rep       Date:  2021-06-28       Impact factor: 4.379

Review 7.  Human CD4(+) T-Cells: A Role for Low-Affinity Fc Receptors.

Authors:  Anil K Chauhan
Journal:  Front Immunol       Date:  2016-06-01       Impact factor: 7.561

Review 8.  Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.

Authors:  Martyn A French; M Christian Tjiam; Laila N Abudulai; Sonia Fernandez
Journal:  Front Immunol       Date:  2017-07-04       Impact factor: 7.561

9.  The innate immune response to ischemic injury: a multiscale modeling perspective.

Authors:  Elena Dimitrova; Leslie A Caromile; Reinhard Laubenbacher; Linda H Shapiro
Journal:  BMC Syst Biol       Date:  2018-04-10

10.  Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells.

Authors:  Melissa Newling; Willianne Hoepel; Lisa T C Vogelpoel; Marieke H Heineke; Johan A van Burgsteden; Esther W M Taanman-Kueter; Dirk Eggink; Taco W Kuijpers; Tim Beaumont; Marjolein van Egmond; Martien L Kapsenberg; Dominique L P Baeten; Jeroen den Dunnen; Esther C de Jong
Journal:  Eur J Immunol       Date:  2018-09-14       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.